When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Clinical-stage biopharmaceutical company, CymaBay Therapeutics ( NASDAQ: CBAY ) announced that seasoned biopharma executive Harish Shantharam, CFA has joined the company as CFO.
Mr. Shantharam brings nearly 20 years of biotech experience leading financial functions with a very strong emphasis on setting strategy and building financial planning and accounting operations to prepare companies for commercial drug launch.
Mr. Shantharam was most recently the Senior Finance Adviser to the CFO at Eikon Therapeutics.